Gemcitabine for Cheplapharm, QA383ESALE
- Manufacturer
- Evonik Corporation
- Effective date
- 2026-09-09
- Label type
- BULK INGREDIENT
- Version
- 10
- Source
- daily-update
- Hydrated at
- 2026-09-22 03:03:13
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
Shipping Nice Label on Outer drum. Sept 2026.
Bulk for Export Only
Caution: For Manufacturing, processing or repacking. Rx Only.
Gemcitabine Hydrochloride
QA383ESALE
99176150
Caution: Toxic, skin permeable, mutagen, irritant (eyes), reproductive, and blood.
Storage Conditions: 8 to 40°C
Batch number:
Manufacture date:
Manufactured and tested by Evonik Corporation, Tippecanoe Laboratories, 1650 Lilly Road, Lafayette, IN 47909
Warehouse KG label, QA383ESALE, Sept 2026
Gemcitabine Hydrochloride GMP
Put-Away Label
Material Number 99176150
Storage Unit Number
Net Weight xx Kg
Lot/Batch
Old Material Number QA383ESALE
QR code box
Storage Conditions: Warehouse temperature
Temperature Conditions: 8°C - 40°C
Skin permeable. Mutagen. Irritant (eyes). Reproductive. Blood.
Highly potent. Acute toxicity, oral. Acute toxicity, dermal.
Health 2
Fire 1
Reactivity 1
Special R (reproductive hazard)
Evonik Corporation
1650 Lilly Road Lafayette, Indiana 47909 USA
Phone: 765-477-4300 Fax: 765-477-4291
Evonik: Leading beyond Chemistry
Emergency Phones:
(Chemtrec 24 h) US & CA 800-424-9300
Mexico 800-681-9531 / Intl. 001-703-527-3887 (collect calls accepted)
Product Linked Resources#
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Data code | QR Code | C010199176150|033720028226|105046042025|968.100|97KG | QA383ESALE_WarehouseLabel_Final.jpg |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| a2b7d477-0e35-4772-8a9d-99c71e3e210b | Product name | 2 | 20190614 |
| 4c31c9b8-06d5-4f83-9eb7-cd946af7067a | Product name | 5 | 20190612 |
| a12a1c0c-65f2-45a0-8bf0-7dfc55c750b6 | Product name | 1 | 20180829 |
| d2980057-8cff-4896-979e-b4c394974cfd | Product name | 1 | 20170829 |
Products#
Every source-derived product name is available through these pages.
- Gemcitabine hydrochloride
- GEMCITABINE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 62128-0383 | 62128-0383-1, 62128-0383-6 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| GEMCITABINE HYDROCHLORIDE | U347PV74IL | ACTIM |
Source Document#
Older Hydrated Versions#
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 9 | 2025-06-27 | full-release | 2026-06-01 02:51:49 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Gemcitabine | GEMCITABINE HYDROCHLORIDE | Meitheal Pharmaceuticals Inc. | c0b1b715-9ff8-43ca-9e49-465f1f380084 | 2025-07-23 | Warnings, Adverse reactions | GEMCITABINE HYDROCHLORIDE |
| GEMCITABINE | GEMCITABINE HYDROCHLORIDE | NorthStar Rx LLC | 5af49a48-f1c0-467d-b5da-ac9f1ae8e34c | 2025-02-03 | Warnings, Adverse reactions | GEMCITABINE HYDROCHLORIDE |
| GEMCITABINE | GEMCITABINE HYDROCHLORIDE | Meitheal Pharmaceuticals Inc. | a5949d02-29eb-4626-ad35-b7614bb0fa95 | 2025-01-29 | Warnings, Adverse reactions | GEMCITABINE HYDROCHLORIDE |
| Gemcitabine hydrochloride | GEMCITABINE HYDROCHLORIDE | Teyro Labs Private Limited | a6ddaa2f-4c17-430f-a7cd-96b6662923f6 | 2025-01-09 | Warnings, Adverse reactions | Gemcitabine hydrochloride GEMCITABINE HYDROCHLORIDE |
| Gemcitabine | GEMCITABINE HYDROCHLORIDE | Mylan Institutional LLC | 06dd9d40-74fc-4409-93b1-a46be7126331 | 2024-11-11 | Warnings, Adverse reactions | GEMCITABINE HYDROCHLORIDE |
| gemcitabine hydrochloride | GEMCITABINE HYDROCHLORIDE | Gland Pharma Limited | 9f8fe5ba-943f-4f0a-9618-6083101faa28 | 2024-09-06 | Warnings, Adverse reactions | gemcitabine hydrochloride GEMCITABINE HYDROCHLORIDE |
| Gemcitabine | GEMCITABINE HYDROCHLORIDE | Meitheal Pharmaceuticals Inc. | 73ae04d8-38f9-4d3d-b0c2-71d22af1fc86 | 2024-08-05 | Warnings, Adverse reactions | GEMCITABINE HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.

